These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18797934)

  • 21. Exposure of the Gestating Mother to Sympathetic Stress Modifies the Cardiovascular Function of the Progeny in Male Rats.
    Piquer B; Olmos D; Flores A; Barra R; Bahamondes G; Diaz-Araya G; Lara HE
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury.
    Takahashi H; Takeishi Y; Arimoto T; Shishido T; Konta T; Koyama Y; Niizeki T; Kubota I
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):487-93. PubMed ID: 16160602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats.
    Paterno JC; Bergamaschi CT; Campos RR; Higa EM; Soares MF; Schor N; Freire AO; Teixeira VP
    Kidney Blood Press Res; 2012; 35(5):355-64. PubMed ID: 22473039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of the activated mammalian target of rapamycin pathway might be associated with renal function reserve by a low-protein diet in the rat remnant kidney model.
    Ohkawa S; Yanagida M; Uchikawa T; Yoshida T; Ikegaya N; Kumagai H
    Nutr Res; 2013 Sep; 33(9):761-71. PubMed ID: 24034576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER.
    Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM
    Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation of the sympathetic nervous system in hypertension in rats with subtotal renal ablation.
    Yuhara M; Ikeda T; Toya Y; Sakurai J; Gomi T; Ikeda T
    J Hypertens; 1989 Jun; 7(6):443-6. PubMed ID: 2778311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein kinase C and extracellular signal regulated kinase are involved in cardiac hypertrophy of rats with progressive renal injury.
    Takahashi H; Takeishi Y; Miyamoto T; Shishido T; Arimoto T; Konta T; Miyashita T; Ito M; Kubota I
    Eur J Clin Invest; 2004 Feb; 34(2):85-93. PubMed ID: 14764070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation of effects of hypertrophy from hypertension on cardiac beta-receptors in renovascular hypertensive rats.
    Alicandri CL; Agabiti-Rosei E; Ayobe HM; Muiesan G; Tarazi RC
    J Hypertens Suppl; 1983 Dec; 1(2):82-4. PubMed ID: 6100617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes.
    Zheng JS; Boluyt MO; Long X; O'Neill L; Lakatta EG; Crow MT
    Circ Res; 1996 Apr; 78(4):525-35. PubMed ID: 8635209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis of cardiac hypertrophy.
    Yamazaki T; Yazaki Y
    Z Kardiol; 2000 Jan; 89(1):1-6. PubMed ID: 10663910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter.
    Parrish DC; Gritman K; Van Winkle DM; Woodward WR; Bader M; Habecker BA
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H99-H106. PubMed ID: 17951370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling responses after exposure to 5 alpha-dihydrotestosterone or 17 beta-estradiol in norepinephrine-induced hypertrophy of neonatal rat ventricular myocytes.
    Koshman YE; Piano MR; Russell B; Schwertz DW
    J Appl Physiol (1985); 2010 Mar; 108(3):686-96. PubMed ID: 20044473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inverse blood pressure rhythm of transgenic hypertensive TGR(mREN2)27 rats: role of norepinephrine and expression of tyrosine-hydroxylase and reuptake1-transporter.
    Lemmer B; Schiffer S; Witte K; Gorbey S
    Chronobiol Int; 2005; 22(3):473-88. PubMed ID: 16076648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
    Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L
    Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dimethyl fumarate interferes with MyD88-dependent toll-like receptor signalling pathway in isoproterenol-induced cardiac hypertrophy model.
    Ahmed AA; Ahmed AAE; El Morsy EM; Nofal S
    J Pharm Pharmacol; 2018 Nov; 70(11):1521-1530. PubMed ID: 30175489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of atrial contraction by PKA and PKC during the compensated phase of eccentric cardiac hypertrophy.
    Haddad GE; Coleman BR; Zhao A; Blackwell KN
    Basic Res Cardiol; 2004 Sep; 99(5):317-27. PubMed ID: 15309409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uninephrectomy prevents the ischemia-induced increase in renin activity.
    Kato A; Hishida A; Tanaka I; Komatsu K
    Nephron; 1997; 75(1):72-6. PubMed ID: 9031273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats.
    Flanagan ET; Buckley MM; Aherne CM; Lainis F; Sattar M; Johns EJ
    Exp Physiol; 2008 Sep; 93(9):1058-64. PubMed ID: 18487313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in β-adrenoceptor system in cardiac hypertrophy due to arteriovenous fistula.
    Dent MR; Tappia PS; Dhalla NS
    J Cell Physiol; 2011 Jan; 226(1):181-6. PubMed ID: 20677219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade.
    Halleck F; Schröder K; Holleck-Weithmann S; Kossmehl P; Kreutz R; Rothermund L
    Clin Exp Hypertens; 2015; 37(1):26-32. PubMed ID: 24678912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.